Hospital-Level psychiatric care comes home in new pilot study
NCT ID NCT07364825
First seen Jun 25, 2026 · Last updated Jul 08, 2026 · Updated 3 times
Summary
This pilot study is testing whether adults with serious mental health issues like psychosis, anxiety, or depression can receive hospital-level care in their own homes. Researchers will see how many people are eligible and willing to try this approach. The goal is to offer a safe, comfortable alternative to traditional hospital stays.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Behavioral Health Home Hospital (home-based psychiatric care)
- What this could lead to
- If successful, this could offer a safe, comfortable alternative to hospital stays for people with acute mental health conditions.
- What could go wrong
- This is a very small pilot study (41 people) and only looks at eligibility and retention, not whether home care is as effective as hospital care. It may not work for everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
41 people
The number who actually took part.
- Started
-
Jan 2026
- Finished
-
May 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
General patient inclusion criteria: ≥18 years old Resides or will reside during hospital care within a 10-mile geographic area surrounding BWFH or BWH. Patients must be able to be safely managed at home with the in-home clinical coverage and monitoring provided by the BHH program, as determined by the BHH MD. If the BHH MD determines that caregiver support is required for safe participation, the patient must have a caregiver who is able to provide the required level of support to be eligible for enrollment. The level of caregiver support will be determined on a case-by-case basis by the patient's clinical team and BHH MD based on the patient's clinical presentation, safety needs, and functional status (see section 6.1 for details) To participate in the study, the patient must agree to the level of in-home support and monitoring determined by the study doctor and clinical team. This could include the possibility of asking the patient to agree to be in the same home with their caregiver 24/7 during their entire hospitalization. Patient clinical inclusion criteria Voluntarily consent to BHH admission (patient or proxy consent; if proxy consents, patient assents) Requires hospital-level care for anxiety/depression, psychosis, or behavioral and psychological symptoms of dementia (BPSD) No current restraint use No catatonia Has capacity to consent OR can assent to study and has proxy who can consent Does not need in person socialization that cannot be provided remotely Can reliably communicate with the BHH team (self or caregiver) Does not need safety monitoring more frequently than every 30 minutes Medical condition(s) manageable by BHH Is not a risk of harm to others, and meets the following criteria: Has not harmed staff in the past Consider excluding for a score \>1 on the Broset Violence Checklist Consider prior harm to others; determine context surrounding prior harm, consider other collateral information from family, friends, and other providers Is not a risk of harm to self, and meets the following criteria: SAFE-T Protocol with a Columbia-Suicide Severity Rating Scale (C-SSRS) that is low or moderate risk No evidence of alcohol intoxication or risk of severe withdrawal No active substance use or if substance use then they can abstain during hospitalization (Consider any active treatment plan, type of substance used, and access to substances) Consider previous suicide attempts, intensity, lethality, and compulsivity of self-harm behaviors when determining eligibility Patient does not have behaviors that would prevent them from being cared for at home: Modified Agitation Severity Scale (MASS) score \< 6 Does not have lack of insight or severe disorganization Pittsburgh Agitation Scale score \< 3. Consider excluding the patient for a score of 3 or 4. Patient diagnosis-specific inclusion criteria: If patient has a diagnosis of psychosis: They have NOT developed ideas/beliefs which are significantly detached from the shared beliefs of others If patient has a diagnosis of BPSD, patient must: Have an identifiable treatment goal Be willing and able to participate in therapeutic care Agree to wear the Angelsense device Patient environmental inclusion criteria: HITS Screening Tool for Domestic Violence (requires patient interview) negative Is not in police custody Is not undomiciled Does not reside in a skilled nursing facility, long term acute care hospital, or detoxification facility Residence has the capacity to be therapeutic and has working heat (Oct-Apr), working air conditioner if forecast \>80 F (Jun-Sep), running water, electricity, and no suspected bed bugs, lice, or scabies No direct access to a firearm (even if stored) No illicit drugs in the home Willing and able to secure pets during BHH visits Willing to secure medications and other substances, including marijuana, in a BHH lockbox during BHH Has access to their home (e.g., keys to get into their house) Caregiver inclusion criteria (caregiver is not required to participate in the study; if a caregiver does enroll in the study, the following inclusion criteria apply) Age \>= 18 years old Has capacity to consent to study Clinician inclusion criteria A BHH clinical team member (a clinician providing care in the home, in-person or remotely). Or a clinician at the hospital providing care to a control patient
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Anxiety are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Brigham and Women's Faulkner Hospital
Jamaica Plain, Massachusetts, 02130, United States
-
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
McLean Hospital
Belmont, Massachusetts, 02478, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Gut bacteria may hold clues to dozens of diseases
- VR headset may calm kids before heart procedure
- Can a Text-Message program help trauma survivors avoid PTSD and depression?
- Can a website help young people understand depression?
- Could a whiff of xenon replace the Pre-Surgery chill pill?
- Can a pencil and paper calm anxious teens with diabetes?